These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 33622577

  • 21. Improved long-term outcomes after resection of pancreatic adenocarcinoma: a comparison between two time periods.
    Serrano PE, Cleary SP, Dhani N, Kim PT, Greig PD, Leung K, Moulton CA, Gallinger S, Wei AC.
    Ann Surg Oncol; 2015 Apr; 22(4):1160-7. PubMed ID: 25348784
    [Abstract] [Full Text] [Related]

  • 22. Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas.
    Lenkiewicz E, Malasi S, Hogenson TL, Flores LF, Barham W, Phillips WJ, Roesler AS, Chambers KR, Rajbhandari N, Hayashi A, Antal CE, Downes M, Grandgenett PM, Hollingsworth MA, Cridebring D, Xiong Y, Lee JH, Ye Z, Yan H, Hernandez MC, Leiting JL, Evans RM, Ordog T, Truty MJ, Borad MJ, Reya T, Von Hoff DD, Fernandez-Zapico ME, Barrett MT.
    Cancer Res; 2020 Oct 15; 80(20):4324-4334. PubMed ID: 32928922
    [Abstract] [Full Text] [Related]

  • 23. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
    Ilmer M, Schiergens TS, Renz BW, Schneider C, Sargut M, Waligora R, Weniger M, Hartwig W, Ceyhan GO, Friess H, Werner J, D'Haese JG.
    Surg Oncol; 2019 Dec 15; 31():16-21. PubMed ID: 31473583
    [Abstract] [Full Text] [Related]

  • 24. Clinicopathological features and surgical outcomes of adenosquamous carcinoma of the pancreas: a retrospective analysis of patients with resectable stage tumors.
    Komatsu H, Egawa S, Motoi F, Morikawa T, Sakata N, Naitoh T, Katayose Y, Ishida K, Unno M.
    Surg Today; 2015 Mar 15; 45(3):297-304. PubMed ID: 24973941
    [Abstract] [Full Text] [Related]

  • 25. Surgical outcome of adenosquamous carcinoma of the pancreas.
    Okabayashi T, Hanazaki K.
    World J Gastroenterol; 2008 Nov 28; 14(44):6765-70. PubMed ID: 19058301
    [Abstract] [Full Text] [Related]

  • 26. A case-matched comparison study of total pancreatectomy versus pancreaticoduodenectomy for patients with pancreatic ductal adenocarcinoma.
    Xiong J, Wei A, Ke N, He D, Chian SK, Wei Y, Hu W, Liu X.
    Int J Surg; 2017 Dec 28; 48():134-141. PubMed ID: 29081373
    [Abstract] [Full Text] [Related]

  • 27. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma.
    Yopp AC, Katabi N, Janakos M, Klimstra DS, D'Angelica MI, DeMatteo RP, Fong Y, Brennan MF, Jarnagin WR, Allen PJ.
    Ann Surg; 2011 May 28; 253(5):968-74. PubMed ID: 21422912
    [Abstract] [Full Text] [Related]

  • 28. Reappraisal of Total Pancreatectomy in 45 Patients With Pancreatic Ductal Adenocarcinoma in the Modern Era Using Matched-Pairs Analysis: Multicenter Study Group of Pancreatobiliary Surgery in Japan.
    Satoi S, Murakami Y, Motoi F, Sho M, Matsumoto I, Uemura K, Kawai M, Kurata M, Yanagimoto H, Yamamoto T, Mizuma M, Unno M, Kinoshita S, Akahori T, Shinzeki M, Fukumoto T, Hashimoto Y, Hirono S, Yamaue H, Honda G, Kwon M.
    Pancreas; 2016 Aug 28; 45(7):1003-9. PubMed ID: 26692442
    [Abstract] [Full Text] [Related]

  • 29. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT, Warshaw AL, Allen JN, Blaszkowsky LS, Castillo CF, Deshpande V, Hong TS, Kwak EL, Lauwers GY, Ryan DP, Wargo JA, Lillemoe KD, Ferrone CR.
    Ann Surg; 2013 Apr 28; 257(4):731-6. PubMed ID: 22968073
    [Abstract] [Full Text] [Related]

  • 30. Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal adenocarcinoma.
    Chen H, Xu Z, Shen Z, Weng Y, Wang W, Ying X, Wang X, Deng X, Shen B.
    Eur J Surg Oncol; 2022 May 28; 48(5):1062-1067. PubMed ID: 34887166
    [Abstract] [Full Text] [Related]

  • 31. [A clinical series of 80 patients with adenosquamous carcinoma of pancreas].
    Song B, Liu X, Ma H, Ji W, Shao C, Hu X, Jin G.
    Zhonghua Wai Ke Za Zhi; 2014 Sep 28; 52(9):658-61. PubMed ID: 25410777
    [Abstract] [Full Text] [Related]

  • 32. Prognostic impact of lymph node status in patients after total pancreatectomy for pancreatic ductal adenocarcinoma: A strobe-compliant study.
    Zheng ZJ, Wang MJ, Tan CL, Chen YH, Ping J, Liu XB.
    Medicine (Baltimore); 2020 Feb 28; 99(8):e19327. PubMed ID: 32080152
    [Abstract] [Full Text] [Related]

  • 33. Pancreatic volume is one of the independent prognostic factors for resectable pancreatic ductal adenocarcinomas.
    Fukumoto T, Watanabe T, Hirai I, Kimura W.
    J Hepatobiliary Pancreat Sci; 2016 Aug 28; 23(8):472-9. PubMed ID: 27246905
    [Abstract] [Full Text] [Related]

  • 34. [Surgical therapy of pancreatic cancer - 5 years survival].
    Loveček M, Skalický P, Klos D, Neoral Č, Ehrmann J, Zapletalová J, Švébišová H, Yogeswara T, Ghothim M, Vrba R, Havlík R.
    Rozhl Chir; 2015 Nov 28; 94(11):470-6. PubMed ID: 26766155
    [Abstract] [Full Text] [Related]

  • 35. Central pancreatectomy for early-stage pancreatic ductal adenocarcinoma: a single-center case-control study.
    Gao H, Liu T, Wang G, Gao Y, Yin L, Peng Y, Lyu N, Zhang K, Gao W, Wu J, Jiang K, Wei J, Miao Y.
    Langenbecks Arch Surg; 2019 Mar 28; 404(2):175-182. PubMed ID: 30826926
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of the prognostic factors and significance of lymph node status in invasive ductal carcinoma of the body or tail of the pancreas.
    Fujita T, Nakagohri T, Gotohda N, Takahashi S, Konishi M, Kojima M, Kinoshita T.
    Pancreas; 2010 Jan 28; 39(1):e48-54. PubMed ID: 19910836
    [Abstract] [Full Text] [Related]

  • 37. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ, Jin C, Fu DL.
    World J Gastroenterol; 2016 Dec 07; 22(45):10024-10037. PubMed ID: 28018110
    [Abstract] [Full Text] [Related]

  • 38. Loss of chromosome 9p21 is associated with a poor prognosis in adenosquamous carcinoma of the pancreas.
    Jiang Y, Wu Y, Zhang L, Wang Y, Xu G, Deng Y, Han L, Li E, Ma Q, Xu M, Wu Z, Wang Z.
    Precis Clin Med; 2023 Dec 07; 6(4):pbad030. PubMed ID: 38024139
    [Abstract] [Full Text] [Related]

  • 39. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
    Partelli S, Crippa S, Barugola G, Tamburrino D, Capelli P, D'Onofrio M, Pederzoli P, Falconi M.
    Ann Surg Oncol; 2011 Dec 07; 18(13):3608-14. PubMed ID: 21584836
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of preoperative prognostic factors in patients with resectable pancreatic ductal adenocarcinoma.
    Izumo W, Higuchi R, Furukawa T, Yazawa T, Uemura S, Shiihara M, Yamamoto M.
    Scand J Gastroenterol; 2019 Jun 07; 54(6):780-786. PubMed ID: 31180790
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.